These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22967858)

  • 1. Non-human primate FOG develops with advanced parkinsonism induced by MPTP Treatment.
    Revuelta GJ; Uthayathas S; Wahlquist AE; Factor SA; Papa SM
    Exp Neurol; 2012 Oct; 237(2):464-9. PubMed ID: 22967858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
    Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
    J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-human primate model for stable chronic Parkinson's disease induced by MPTP administration based on individual behavioral quantification.
    Seo J; Lee Y; Kim BS; Park J; Yang S; Yoon HJ; Yoo J; Park HS; Hong JJ; Koo BS; Baek SH; Jeon CY; Huh JW; Kim YH; Park SJ; Won J; Ahn YJ; Kim K; Jeong KJ; Kang P; Lee DS; Lim SM; Jin YB; Lee SR
    J Neurosci Methods; 2019 Jan; 311():277-287. PubMed ID: 30391524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
    Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
    Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical spectrum of freezing of gait in atypical parkinsonism.
    Factor SA
    Mov Disord; 2008; 23 Suppl 2():S431-8. PubMed ID: 18668624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease.
    Schaafsma JD; Balash Y; Gurevich T; Bartels AL; Hausdorff JM; Giladi N
    Eur J Neurol; 2003 Jul; 10(4):391-8. PubMed ID: 12823491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of freezing of gait in distinct Parkinsonism types by diffusion tensor imaging method and cognitive profiles.
    Onder H; Oguz KK; Has AC; Elibol B
    J Neural Transm (Vienna); 2023 Apr; 130(4):521-535. PubMed ID: 36881182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freezing of gait in patients with advanced Parkinson's disease.
    Giladi N; Treves TA; Simon ES; Shabtai H; Orlov Y; Kandinov B; Paleacu D; Korczyn AD
    J Neural Transm (Vienna); 2001; 108(1):53-61. PubMed ID: 11261746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opicapone enhances the reversal of MPTP-induced Parkinson-like syndrome by levodopa in cynomolgus monkeys.
    Bonifácio MJ; Sousa F; Soares-da-Silva P
    Eur J Pharmacol; 2021 Feb; 892():173742. PubMed ID: 33220276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections.
    Li H; Lei X; Huang B; Rizak JD; Yang L; Yang S; Wu J; Lü L; Wang J; Yan T; Li H; Wang Z; Hu Y; Le W; Deng X; Li J; Xu L; Zhang B; Hu X
    J Neurosci Methods; 2015 Aug; 251():99-107. PubMed ID: 26003862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new rating instrument to assess festination and freezing gait in Parkinsonian patients.
    Ziegler K; Schroeteler F; Ceballos-Baumann AO; Fietzek UM
    Mov Disord; 2010 Jun; 25(8):1012-8. PubMed ID: 20310009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism.
    Xu M; Bohlen JK; Moore C; Nipper MA; Finn DA; Jones CE; Lim MM; Meshul CK
    J Neurosci Res; 2019 Dec; 97(12):1706-1719. PubMed ID: 31535395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset.
    Hamadjida A; Nuara SG; Kwan C; Frouni I; Bédard D; Gourdon JC; Huot P
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2157-2164. PubMed ID: 32621059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series.
    Joers V; Masilamoni G; Kempf D; Weiss AR; Rotterman TM; Murray B; Yalcin-Cakmakli G; Voll RJ; Goodman MM; Howell L; Bachevalier J; Green SJ; Naqib A; Shaikh M; Engen PA; Keshavarzian A; Barnum CJ; Nye JA; Smith Y; Tansey MG
    Neurobiol Dis; 2020 Oct; 144():105027. PubMed ID: 32712266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associated factors and abnormal dorsal raphe nucleus connectivity patterns of freezing of gait in Parkinson's disease.
    Lv L; Zhang H; Tan X; Long Z; Qin L; Bai R; Xiao Q; Wu Z; Hu S; Tan C; Liao H; Yan W; Tang B; Ren F; Wang C
    J Neurol; 2022 Dec; 269(12):6452-6466. PubMed ID: 35933494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease.
    McKay JL; Nye J; Goldstein FC; Sommerfeld B; Smith Y; Weinshenker D; Factor SA
    Neurobiol Dis; 2023 Apr; 179():106048. PubMed ID: 36813207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus).
    Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE
    Neuroscience; 1997 Dec; 81(3):745-55. PubMed ID: 9316026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental parkinsonism.
    Baufreton J; Milekovic T; Li Q; McGuire S; Moraud EM; Porras G; Sun S; Ko WKD; Chazalon M; Morin S; Normand E; Farjot G; Milet A; Pype J; Pioli E; Courtine G; Bessière B; Bezard E
    Mov Disord; 2018 Oct; 33(10):1632-1642. PubMed ID: 29756234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys.
    Goulet M; Madras BK
    J Pharmacol Exp Ther; 2000 Feb; 292(2):714-24. PubMed ID: 10640310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.